Fluofarma maintains a panel of over 100 validated cell-based assays allowing the quantification of key phenotypic and molecular events at the single-cell level. Most of the cellular assays listed below can be transferred to a different biological model, o...
MORE INFORMATIONEvery week, Fluofarma's generates over 400 gigabits of raw data. To make the most of HCA experiments, we developed automated software solutions for fast data analysis, quality control and data visualization.
MORE INFORMATIONAs a cell biology company, our prime focus is to test compounds in physiologically relevant cellular models, to better predict future clinical outcomes. We work with cell lines, primary cells and stem cells to design tissue- and disease-specific in vitro ...
MORE INFORMATIONInnovative drug discovery strategies call for new assays and drug testing methodologies. Specialized in High Content Analysis, we have been developing custom cell-based assays and biomarker assays for the past ten years.
MORE INFORMATIONHigh-content analysis (HCA) is about extracting maximum information from cell biology experiments, using automated, multiplexed and miniaturized technologies, so as to generate highly-reproducible data, while reducing operating costs and turnaround time.
MORE INFORMATIONZ.A. de Glatigné
53940 Le Genest-Saint-Isle, France
Telephone +33 243 693 607
Contact us